This brief provides an overview of the tele-PrEP landscape, including how PrEP services (e.g., consults, lab work, prescribing, and monitoring) are provided and factors that facilitate its provision as well as barriers that remain. It is based on in-depth interviews with representatives from the major national telehealth companies providing tele-PrEP and other select tele-PrEP programs.
- view as grid
- view as list
New KFF Brief Takes a Closer Look at “Tele-PrEP” and the Future of PrEP Services in the United States
In 2020, only 25% of people who could benefit from pre-exposure prophylaxis (PrEP), a medication that reduces the risk of acquiring HIV, were prescribed it. Using telehealth to provide PrEP, “tele-PrEP,” is a new approach that shows potential for expanding access to PrEP use in the United States that predates…
President Biden released his full FY 2023 budget request on March 28, 2022. The President’s second budget request builds on past efforts to address the domestic HIV response, including by proposing funding increases for the “Ending the HIV Epidemic” (EHE) initiative. The EHE was launched by the Trump Administration in…
This tracker provides up-to-date data on federal Ending the HIV Epidemic (EHE) funding, including an overview of funding mechanisms by year, agency, grant mechanism, and jurisdiction. It will be updated over time.
People With HIV in Non-Medicaid Expansion States: Who Could Gain Coverage Eligibility Through Build Back Better or Future Expansion?
In this analysis, we explore the implications of the Build Back Better Act’s current coverage provisions for people with HIV in select non-expansion states. We estimate the size of the population that could gain eligibility as well as their socio-demographic characteristics, examine their affordability barriers and assess the potential impact on the Ryan White HIV/AIDS Program. We also explore what Medicaid expansion could mean in these non-expansion states for people with HIV.
Recent and Anticipated Actions to Reverse Trump Administration Section 1557 Non-Discrimination Rules
The Biden Administration has started taking steps to reverse Trump Administration policy and regulations that significantly narrowed the implementation and administrative enforcement of Section 1557, the Affordable Care Act’s nondiscrimination provision, particularly as the regulations apply to gender identity and sexual orientation. In addition, several lawsuits challenging the regulations, which…
This updated fact sheet provides the latest data on the U.S. HIV epidemic, including key trends over time, impact by region and population, and information on the U.S. government’s response.
This brief examines and summarizes what we know about COVID-19 and HIV including, what we know about COVID-19 risk, disease severity, vaccination, and federal response. It also explores how people with HIV are overly represented in many of the demographic groups hardest hit by the pandemic.
In this article for The Lancet, KFF’s Jennifer Kates and Lindsey Dawson, and five co-authors provide an overview of the coverage and financing landscape for HIV treatment and prevention in the U.S., discuss how the Affordable Care Act has changed the domestic health care system, examine the major programs that…
This explainer provides an overview of the federal “Ending the HIV Epidemic” initiative and explores issues that might mitigate or facilitate its success.